Insiders who bought US$475.8k worth of Verve Therapeutics, Inc.'s (NASDAQ:VERV) stock at an average buy price of US$6.26 over the last year may be disappointed by the recent 25% decrease in the stock....
Source LinkInsiders who bought US$475.8k worth of Verve Therapeutics, Inc.'s (NASDAQ:VERV) stock at an average buy price of US$6.26 over the last year may be disappointed by the recent 25% decrease in the stock....
Source Link
Comments